How to Buy Lexicon Pharmaceuticals Stock
Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.
Lexicon Pharmaceuticals stock last closed at $0.58, up 12.75% from the previous day, and has decreased 66.37% in one year. It has overperformed other stocks in the Biotechnology industry by 0.11 percentage points. Lexicon Pharmaceuticals stock is currently +102.46% from its 52-week low of $0.28, and -76.53% from its 52-week high of $2.45.
At the moment, there are 361.49M LXRX shares outstanding. The market capitalization of LXRX is $207.86M. In the past 24 hours, 10.03M LXRX shares were traded.
How to Buy Lexicon Pharmaceuticals Stock
Not sure how to invest in Lexicon Pharmaceuticals stock? Here's how.
- Figure out where to buy Lexicon Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Lexicon Pharmaceuticals stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Pick your method of payment and add your info.
- Research Lexicon Pharmaceuticals stock: The Lexicon Pharmaceuticals ticker symbol is LXRX. Is Lexicon Pharmaceuticals stock a good investment? Should you buy shares of LXRX? How do LXRX's underlying business fundamentals look? Do top analysts think Lexicon Pharmaceuticals is a good buy? Why has LXRX's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if LXRX is a good stock to buy).
- Make your LXRX buy order: Decide if you will purchase LXRX shares at the current market price or use a limit order to buy LXRX shares at a specific price.
- Keep an eye on your LXRX investment: Create a watchlist to watch your investment in Lexicon Pharmaceuticals shares.
Step 1: Figure out where to buy Lexicon Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy LXRX shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in LXRX today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new brokerage account.
- Submit your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have created your account on a good stock buying app, your next step is to transfer the money for your investment:
Watch the walkthrough below if you need help transferring funds into your brokerage account.
Step 4: Research Lexicon Pharmaceuticals stock
Once you have decided on the best place to buy Lexicon Pharmaceuticals stock, it's crucial to evaluate their stock before you buy, so you actually understand the risk as well as the opportunity.
Overview of key LXRX info
LXRX Overview
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on LXRX's stock page.
Is LXRX stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge LXRX's fair value.
Using relative valuations measures:
- LXRX could be undervalued based on its P/B ratio of 1.42x, relative to Biotechnology industry P/B ratio of 4.04x
You can do more valuation research on LXRX's stock here.
How do LXRX Financials look?
Positive Financial Indicators:
- LXRX has cash burn of 179811000. It has enough cash and short-term investments to cover this for at least one year.
- Total LXRX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the LXRX balance sheet.
- There are more short-term assets than long-term liabilities on the LXRX balance sheet.
Negative Financial Indicators:
- LXRX profit margin has gone up by 140.66 percentage points in the past year, but the company is still unprofitable.
- LXRX has a relatively high debt to equity ratio of 1.05.
- LXRX has $237.96M in cash and short term investments. This is not enough to cover its annual cash burn of $179.81M.
Is it a good time to buy Lexicon Pharmaceuticals stock, according to analysts?
Out of 3 Equities analysts who give ratings on LXRX, the consensus analyst rating on Lexicon Pharmaceuticals is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Lexicon Pharmaceuticals stock forecast page.
LXRX Momentum
LXRX Performance Numbers
Last year, LXRX revenue was $31.08M. During the past 5 year, LXRX's revenue has gone up by -37.35% per year. This was slower than the Biotechnology industry average of 44.31%.
Dig into LXRX's earnings and revenue performance here.
Who is buying/selling LXRX?
In the last 12 months, insiders at LXRX have sold more shares than they have bought.
Kristen Alexander, VP Finance and Accounting of LXRX, was the latest LXRX insider to sell. They sold $11,967.54 worth of LXRX stock on Feb 28, 2025.
Get more info about who owns LXRX shares here.
Can I get consistent income from LXRX stock?
No, Lexicon Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your LXRX buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and your broker will place the order.
If you require additional help with buying stocks on eToro, click the how to video below:
Step 6: Keep an eye on your LXRX investment
Now that you own some shares in LXRX, you'll want to keep up with your new stock purchase.
Start a watchlist to get notified of important updates regarding your LXRX stock.
LXRX Feed
How to Buy Stock in Lexicon Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Lexicon Pharmaceuticals stock right now:
- Figure out where to buy Lexicon Pharmaceuticals stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Research Lexicon Pharmaceuticals stock
- Make your LXRX buy order
- Keep an eye on your LXRX investment
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Lexicon Pharmaceuticals, hit the button below to create your watchlist.
Other Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.